SYNTHESIS AND EVALUATION OF OLMESARTAN MEDOXOMIL COMPLEX WITH SBE7 β-CD FOR ENHANCED DISSOLUTION AND BIOAVAILABILITY
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2016, Vol 8, Issue 1
Abstract
Objective: Olmesartan is a BCS class II anti-hypertensive drug with limitations of low aqueous solubility and bioavailability. ÂÂPresent work was designed to use complexation as an approach to explore the ability of modified cyclodextrin such as sulphobutyl ether7 β-cyclodextrin (SBE7β-CD) to develop an inclusion complex with poorly soluble olmesartan medoxomil (OLM) for improving its dissolution rate and relative bioavailability.Methods: Inclusion complexes were prepared by different techniques of physical mixing, kneading and lyophilisation. Prepared complexes were characterized by differential scanning calorimetry (DSC), powder x-ray diffractometry (X-RPD), proton nuclear magnetic spectroscopy (1H NMR) and fourier transforms infrared spectroscopy (FT-IR). Molecular interaction and encapsulation in an inclusion complex at the molecular level were considered using docking chemistry. Results: Phase solubility analysis revealed 13 fold increase in aqueous solubility with stability constant Ks=249 M−1at 1:1 stoichiometry of complexation. DSC and XPRD confirmed the reduction of crystallinity in complexes with improved solubility. 1H NMR and FT-IR studies depicted the interaction among functional groups with varied hydrogen shifts confirmed by molecular modelling. Dissolution studies of complexes have shown an improved dissolution rate when compared to plain OLM. Pharmacokinetic profile of OLM/SBE7β-CD has shown a significant enhancement in the relative bioavailability.Conclusion: SBE7β-CD may be successfully used as a carrier for the oral administration of OLM with enhanced bioavailability subjected to future scale up.Â
Authors and Affiliations
Sonia Gera, Srikanth Cheruvu, Ashok Zakkula, Sunitha Sampathi
Keywords
Related Articles
- EP ID EP577965
- DOI -
- Views 72
- Downloads 0
DUBIOUS ANTI-OBESITY AGENT HCA FROM GARCINIA: A SYSTEMATIC REVIEW
Obesity is a complex disorder of appetite regulation and energy metabolism controlled by specific biological factors. Whenever prevention fails, medicinal treatment of obesity may become an obligation and it is more frui...
CLEANING VALIDATION FOR ESTIMATION OF ACTIVE INGREDIENTS’ RESIDUES OF VICAZID UNCOATED TABLETS (PYRANTEL 100 MG/MEBENDAZOLE 150 MG) ON SURFACES OF PHARMACEUTICAL MANUFACTURING EQUIPMENT USING SWAB SAMPLING AND HPLC METHOD
Objective: The validation of HPLC methods for residual estimation of pyrantel and mebendazole in swab samples from equipment surfaces after manufacturing of Vicazid uncoated tablets and the demonstration of the efficienc...
IN VITRO EVALUATION OF THE NON-CYTOTOXIC THYMUS CAPITATUS EXTRACTS INHIBIT BOVINE HERPESVIRUS-1 EXPANSION
Objective: Bovine herpes virus type 1 (BHV-1) is an important cofactor in the bovine respiratory disease complex with high health and financial impact because there aren’t any available drugs that proved to be fully ef...
MOLECULAR DOCKING, PHARMACOPHORE MODELLING, AND ADME-TOXICITY PREDICTION OF CURCUMIN ANALOG COMPOUNDS AS INFLAMMATORY INHIBITOR ON RHEUMATOID ARTHRITIS
Objective: The objective of this research was to examine the activity and cytokine inhibitory mechanism of curcumin analog compound against multiple protein targets in a patient with rheumatoid arthritis (RA) and identif...
A CASE REPORT: DRUG INTERACTION BETWEEN LINEZOLID AND DOPAMINE
Linezolid is a weak, non-selective inhibitor of monoamine oxidase (MAO). It can inhibit the breakdown of the tyramine by MAO in the gut and can also potentiate the effect of tyramine at nerve endings, thereby causing an...